Searchable abstracts of presentations at key conferences in endocrinology

ea0047oc14 | Spotlight on Neuroendocrine tumours | Theranostics2016

68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors – a head-to-head comparison with DOTATOC and FDG PET/CT

Lassmann Michael , Werner Rudolf A. , Weich Alexander , Wester Hans-Juergen , Scheurlen Michael , Higuchi Takahiro , Samnick Samuel , Bluemel Christina , Rudelius Martina , Buck Andreas K. , Lapa Constantin , Herrmann Ken

Introduction: Diagnostic imaging of neuroendocrine tumors (NETs) is the domain of somatostatin receptor (SSTR) agonists as well as FDG PET/CT in dedifferentiated tumors. SSTR also serves as target for receptor directed peptide therapy. More recently, specific ligands targeting the chemokine receptor 4 (CXCR4) were introduced potentially offering an additional theranostic option in NETs. Here we evaluated the CXCR4 expression using 68Ga-Pentixafor PET/CT in NET patie...